Federica Ricci

Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2

Sara Galimberti, Mario Petrini, Claudia Baratè et al. · Frontiers in Oncology · 2020 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

The CoV-2 outbreak: how hematologists could help to fight Covid-19

Sara Galimberti, Chiara Baldini, Claudia Baratè et al. · Pharmacological Research · 2020 · 43 citations · Full text

Medicine, Hematology, Infectious Diseases +5

The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia

Sara Galimberti, Susanna Grassi, Claudia Baratè et al. · Frontiers in Oncology · 2018 · 25 citations · Full text

Medicine, Hematology, Oncology +17

Polycomb Genes are Associated with Response to Imatinib in Chronic Myeloid Leukemia

Francesco Crea, Antonello Di Paolo, Hui Hsuan Liu et al. · Epigenomics · 2015 · 20 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

Susanna Grassi, Sara Palumbo, Veronica Mariotti et al. · Frontiers in Oncology · 2019 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15